Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain

Kirsten A Nyrop, Leigh F Callahan, Christine Rini, Mary Altpeter, Betsy Hackney, Arielle Schecher, Anne Wilson, Hyman B Muss, Kirsten A Nyrop, Leigh F Callahan, Christine Rini, Mary Altpeter, Betsy Hackney, Arielle Schecher, Anne Wilson, Hyman B Muss

Abstract

Adding aromatase inhibitors (AIs) to adjuvant treatment of postmenopausal women with hormone-receptor-positive breast cancer significantly reduces cancer recurrence. A common side effect of AIs is noninflammatory joint pain and stiffness (arthralgia) similar to arthritis symptoms. An evidence-based walking program developed by the Arthritis Foundation - Walk With Ease (WWE) - reduces arthritis-related joint symptoms. We hypothesized that WWE may also reduce AI-associated arthralgia. However, the potential for different barriers and facilitators to physical activity for these 2 patient populations suggested a need to adapt WWE before testing it with breast cancer survivors. We conducted qualitative research with 46 breast cancer survivors to explore program modification and inform the development of materials for an adapted program (Walk With Ease-Breast Cancer). Our process parallels the National Cancer Institute's Research-Tested Intervention Programs (RTIPs) guidelines for adapting evidence-based programs for cancer populations. Findings resulted in a customized 8-page brochure to supplement existing WWE materials.

References

    1. Surveillance Epidemiology and End Results (SEER). SEER stat fact sheets: breast cancer. National Cancer Institute. . Accessed April 29, 2015.
    1. Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer. J Clin Oncol 2010;28(23):3784–96. 10.1200/JCO.2009.26.3756
    1. Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007;8(12):1101–15. 10.1016/S1470-2045(07)70378-9
    1. Dizdar O, Ozçakar L, Malas FU, Harputluoglu H, Bulut N, Aksoy S, et al. Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol 2009;27(30):4955–60. 10.1200/JCO.2008.20.5435
    1. Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007;25(25):3877–83. 10.1200/JCO.2007.10.7573
    1. Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, et al. Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Res Treat 2011;128(2):553–61. 10.1007/s10549-011-1378-5
    1. Presant CA, Bosserman L, Young T, Vakil M, Horns R, Upadhyaya G, et al. Aromatase inhibitor–associated arthralgia and/or bone pain: frequency and characterization in non–clinical trial patients. Clin Breast Cancer 2007;7(10):775–8. 10.3816/CBC.2007.n.038
    1. Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011;126(2):529–37. 10.1007/s10549-010-1132-4
    1. Burstein HJ. Aromatase inhibitor-associated arthralgia syndrome. Breast 2007;16(3):223–34. 10.1016/j.breast.2007.01.011
    1. Khan QJ, O’Dea AP, Sharma P. Musculoskeletal adverse events associated with adjuvant aromatase inhibitors. J Oncol 2010;2010:654348. Published online 2010 Aug 24. 10.1155/2010/654348
    1. Arthritis Foundation. Walk With Ease: your guide to walking for better health, improved fitness and less pain (3rd edition). Atlanta (GA): Arthritis Foundation; 2010.
    1. Callahan LF, Shreffler JH, Altpeter M, Schoster B, Hootman J, Houenou LO, et al. Evaluation of group and self-directed formats of the Arthritis Foundation’s Walk With Ease program. Arthritis Care Res (Hoboken) 2011;63(8):1098–107. 10.1002/acr.20490
    1. Nyrop KA, Cleveland R, Callahan LF. Achievement of exercise objectives and satisfaction with the Walk With Ease program — group and self-directed participants. Am J Health Promot 2014;28(4):228–30. 10.4278/ajhp.120920-ARB-453
    1. Wyatt B, Mingo CA, Waterman MB, White P, Cleveland RJ, Callahan LF. Impact of the Arthritis Foundation’s Walk With Ease program on arthritis symptoms in African Americans. Prev Chronic Dis 2014;11:E199.
    1. National Cancer Institute and Substance Abuse and Mental Health Services Administration. Guidelines for choosing and adapting programs. . Accessed February 5, 2014.
    1. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977;84(2):191–215. 10.1037/0033-295X.84.2.191
    1. Keller C, Fleury J, Gregor-Holt N, Thompson T. Predictive ability of social cognitive theory in exercise research: an integrated literature review. Online J Knowl Synth Nurs 1999;6:2.
    1. Rogers LQ, Matevey C, Hopkins-Price P, Shah P, Dunnington G, Courneya KS. Exploring social cognitive theory constructs for promoting exercise among breast cancer patients. Cancer Nurs 2004;27(6):462–73. 10.1097/00002820-200411000-00006
    1. Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol 2009;28(6):690–701. 10.1037/a0016136
    1. Nyrop KA, Muss HB, Hackney B, Cleveland R, Altpeter M, Callahan LF. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy. J Geriatr Oncol 2014;5(2):148–55. 10.1016/j.jgo.2013.12.002
    1. Schoster B, Altpeter M, Meier A, Callahan LF. Methodological tips for overcoming formative evaluation challenges: the case of the Arthritis Foundation Walk With Ease program. Health Promot Pract 2012;13(2):198–203. 10.1177/1524839910384060
    1. Altundag K, Ibrahim NK. Aromatase inhibitors in breast cancer: an overview. Oncologist 2006;11(6):553–62. 10.1634/theoncologist.11-6-553

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir